Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients

被引:38
|
作者
Xia, Qi [1 ]
Wei, Li [1 ]
Zhang, Yuntao [2 ]
Sheng, Jifang [1 ]
Wu, Wei [1 ]
Zhang, Yi [3 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Dept Intens Care Med, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Dept Lab Med, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[4] Key Lab Clin In Vitro Diagnost Tech Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
SEPSIS; IMMUNOTHERAPY; DYSFUNCTION; CANCER;
D O I
10.1155/2018/1632902
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We aim to investigate the effects of Tim-3 and programmed cell death-1 (PD-1) on the monocytes and T lymphocytes in septic patients. Expression of Tim-3 and PD-1 on the CD3, CD4, and CD8 lymphocytes and monocytes was determined using flow cytometry. CBA technique was utilized to determine the expression of cytokines in the lymphocyte supernatant in addition to the IL-10 and TNF-alpha positivity in monocytes in the presence of Tim-3 and/or PD-1 receptor blockade. Compared with the normal control, significant elevation was observed in the expression of PD-1 on CD3 (P = 0 004), CD4, and CD8 monocytes. Blockade of the Tim-3 signaling pathway contributed to the significant elevation of IL-10 and TNF-alpha in the supernatant of T lymphocytes in the septic patients, while the PD-1 signaling pathway blockade only triggered the obvious elevation of TNF-alpha in the T lymphocytes. Blockade of Tim-3 and PD-1 induced the positivity of IL-10- and TNF-alpha-expressing cells in the peripheral monocytes. Significant changes were noticed in the Tim-3 and PD-1 in the T lymphocytes and monocytes. Blockade of Tim-3 and PD-1 contributed to the function of lymphocytes and monocytes. In the septic process, Tim-3 and PD-1 played crucial roles in the immune response of T lymphocytes and monocytes.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] PD-1 and Tim-3 regulate the expansion of vaccine-induced tumor antigen-specific CD8+T cells in patients with advanced melanoma
    Fourcade, Julien
    Sun, Zhaojun
    Pagliano, Ornella
    Chauvin, Joe-Marc
    Wang, Hong
    Sander, Cindy
    Janjic, Bratislav
    Tarhini, Ahmad
    Tawbi, Hussein
    Kirkwood, John
    Moschos, Stergios
    Guillaume, Philippe
    Luescher, Immanuel
    Krieg, Arthur
    Anderson, Ana
    Kuchroo, Vijay
    Zarour, Hassane
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [42] Serum Concentrations of TIM-3, LAG-3, and PD-1 in Patients with Hemorrhagic Fever with Renal Syndrome
    Safranko, Zeljka Macak
    Jakopec, Lana
    Svagusa, Karla
    Krajinovic, Lidija Cvetko
    Tomasovic, Domagoj
    Lukic, Ljiljana
    Markotic, Alemka
    LIFE-BASEL, 2024, 14 (05):
  • [43] Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis
    Fleury, Michelle
    Belkina, Anna C.
    Proctor, Elizabeth A.
    Zammitti, Christopher
    Simms, Robert W.
    Lauffenburger, Douglas A.
    Snyder-Cappione, Jennifer E.
    Lafyatis, Robert
    Dooms, Hans
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (04) : 566 - 577
  • [44] T-cell Characteristics of Patients with malignant Melanoma as a Function of Therapy with PD-1 Immune Checkpoint Inhibitors
    Werner, M.
    Pfoehler, C.
    Sester, M.
    Schmidt, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 28 - 28
  • [45] Coexpression of Tim-3 and PD-1 of T Lymphocytes Prevents Acute Graft-Versus-Host Disease
    Kim, Jeong-A
    Kim, Jinhang
    Kim, Saetbyeol
    Yang, Misuk
    BLOOD, 2023, 142
  • [46] Expression of the checkpoint receptors LAG-3, TIM-3 and VISTA in peripheral T cell lymphomas
    Murga-Zamalloa, Carlos A.
    Brown, Noah A.
    Wilcox, Ryan A.
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (04) : 197 - 203
  • [47] GENERATION OF AZD7789, A NOVEL PD-1 AND TIM-3 TARGETING BISPECIFIC ANTIBODY, WHICH BINDS TO A DIFFERENTIATED EPITOPE OF TIM-3
    Clancy-Thompson, Eleanor
    Perry, Trinity
    Pryts, Stacy
    Jaiswal, Ashvin
    Oganesyan, Vaheh
    van Dyk, Nydia
    Yang, Chunning
    Garcia, Andrew
    Yu, Wenhan
    Moynihan, James
    Miller, Caroline
    Mulgrew, Kathy
    Cobbold, Mark
    Mazor, Yariv
    Hammond, Scott
    Pollizzi, Kristen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A481 - A481
  • [49] Tim-3, PD-1, CD244 and Foxp3 Positive T Cells? Relation to the Prognosis of Dermatomyositis and Polymyositis Patients
    Ye, Jin
    Liu, Qing
    Fu, Qingqing
    Li, Bin
    Huang, Jinchang
    Zeng, Guoyong
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (04): : 421 - 426
  • [50] Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations
    Kehry, Marilyn
    Horlick, Robert
    Bowers, Peter
    Jun, Toni
    Correia, Jean da Silva
    Graves, Jonathan
    Wang, Yan
    Laken, Haley
    King, David J.
    CANCER RESEARCH, 2015, 75